HeartSciences (HSCS) Cash from Operations (QoQ) (2021 - 2025)
HeartSciences (HSCS) Cash from Operations (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | HeartSciences | 6.51 Mn | 4.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -19.50% |
| Jul 31, 2025 | -22.80% |
| Apr 30, 2025 | 1.82% |
| Jan 31, 2025 | 25.81% |
| Oct 31, 2024 | -8.17% |
| Jul 31, 2024 | -28.03% |
| Apr 30, 2024 | 24.95% |
| Jan 31, 2024 | -112.61% |
| Oct 31, 2023 | 29.63% |
| Jul 31, 2023 | 24.57% |
| Apr 30, 2023 | -82.52% |
| Jan 31, 2023 | 5.57% |
| Oct 31, 2022 | 40.38% |
| Jul 31, 2022 | -51.95% |
| Apr 30, 2022 | -23.39% |
| Jan 31, 2022 | -25.81% |
| Oct 31, 2021 | -7.05% |